Acurx Pharmaceuticals’ (ACXP) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright restated their buy rating on shares of Acurx Pharmaceuticals (NASDAQ:ACXP – Free Report) in a research note released on Wednesday morning,Benzinga reports. HC Wainwright currently has a $12.00 price target on the stock. HC Wainwright also issued estimates for Acurx Pharmaceuticals’ Q1 2025 earnings at ($0.14) EPS, Q2 2025 earnings at ($0.29) EPS, […]
HC Wainwright restated their buy rating on shares of Acurx Pharmaceuticals (NASDAQ:ACXP – Free Report) in a research note released on Wednesday morning,Benzinga reports. HC Wainwright currently has a $12.00 price target on the stock. HC Wainwright also issued estimates for Acurx Pharmaceuticals’ Q1 2025 earnings at ($0.14) EPS, Q2 2025 earnings at ($0.29) EPS, […]
